Skip to main content
European Commission logo
Enterprise Europe Network

French medtech company specialised in cardiovascular imaging is looking for distributors for a medical device solution for post processing of MRI, 4D Flow and CT scan.

Summary

Profile Type
  • Business Offer
POD Reference
BOFR20230221007
Term of Validity
3 March 2023 - 2 March 2025
Company's Country
  • France
Type of partnership
  • Commercial agreement
Targeted Countries
  • Belgium
  • France
  • Spain
  • Egypt
  • Italy
  • Switzerland
  • Tunisia
  • Algeria
  • Germany
  • Portugal
  • Morocco
  • Austria
  • Czechia
  • Luxembourg
  • Lithuania
  • Estonia
  • Malta
  • Greece
  • Ireland
  • Croatia
  • Hungary
  • Poland
  • Finland
  • Latvia
  • Netherlands
  • Bulgaria
  • Cyprus
  • Romania
  • Denmark
  • Sweden
  • Slovenia
  • Slovakia
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
A French company has developed a post-processing software for cardiovascular MRI, 4D Flow and CT scan powered by artificial intelligence. In order to expand the brand, it wants to reinforce its presence worldwide via distributors. The company is seeking cardiology, medical imaging or AI companies with a strong position in different countries and close relationships with radiologists and cardiologists.
Full Description
The solution proposed by the French company is a post-processing software for cardiovascular MRI (magnetic resonance imaging), 4D Flow, and CT (computed tomography) scan based on artificial intelligence and deep-learning algorithms.

It is a class IIa medical device, CE marked since 2017, FDA (Food and Drug Administration) and TFDA (Taiwan Food and Drug Administration) cleared since 2022. Vendor-neutral, the solution is a diagnostic aid for the practitioner, that delivers an automated segmentation to quantify and qualify cardiac imaging information.

Its main objective is to produce fast and accurate analysis, letting physicians focus on patient care and wellness, by intuitively guiding its user through the modalities. Available in 7 languages, it is adapted to the international context in which it operates. Easy to use and compatible with an entry-level computer, it has been designed to meet the demands and needs of physicians to diagnose their patients' cardiovascular pathologies.

This diagnostic software integrates the main sequences for cardiovascular analysis : Cardiac Function and Strain, for cine sequences, Aortic Flow and compliance, delayed enhancement, First Pass and T1, T2, T2* mapping for tissue specification & quantification, with a full report at the end.

A solution for 4D flow analysis is also available, to complete the package.
Advantages and Innovations
The solution is based on Deep learning algorithms, such as the first anatomically guaranteed ventricular contour detection algorithm that substantially reduces contour correction time, and the first algorithm to detect false positives in myocardial infaction for delayed-enhancement MRI sequences.
It reduces analysis time and costs, offers an easy-to-use solution praised for its simplicity.
Stage of Development
  • Already on the market
Sustainable Development Goals
  • Goal 3: Good Health and Well-being
IPR status
  • Secret know-how

Partner Sought

Expected Role of a Partner
Distributors with an existing network of hospitals and clinics and a network of cardiologists and radiologists, that would be able to increase the French company's visibility on-site.

Ideally medtech companies with a knowledge in imaging tools notably MRI, 4D Flow MRI, CT scans,
Type and Size of Partner
  • R&D Institution
  • SME <=10
  • SME 50 - 249
  • SME 11-49
Type of partnership
  • Commercial agreement

Dissemination

Technology keywords
  • 01003003 - Artificial Intelligence (AI)
  • 01004001 - Applications for Health
  • 06001005 - Diagnostics, Diagnosis
  • 06001011 - Heart and blood circulation illnesses
  • 01003006 - Computer Software
Market keywords
  • 005001002 - Medical imaging
Sector Groups Involved
  • Health
Targeted countries
  • Belgium
  • France
  • Spain
  • Egypt
  • Italy
  • Switzerland
  • Tunisia
  • Algeria
  • Germany
  • Portugal
  • Morocco
  • Austria
  • Czechia
  • Luxembourg
  • Lithuania
  • Estonia
  • Malta
  • Greece
  • Ireland
  • Croatia
  • Hungary
  • Poland
  • Finland
  • Latvia
  • Netherlands
  • Bulgaria
  • Cyprus
  • Romania
  • Denmark
  • Sweden
  • Slovenia
  • Slovakia